{\rtf1\ansi\ansicpg1252\uc1\deff0\stshfdbch0\stshfloch0\stshfhich0\stshfbi0\deflang1033\deflangfe1033{\fonttbl{\f0\froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f1\fswiss\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}
{\f36\froman\fcharset238\fprq2 Times New Roman CE;}{\f37\froman\fcharset204\fprq2 Times New Roman Cyr;}{\f39\froman\fcharset161\fprq2 Times New Roman Greek;}{\f40\froman\fcharset162\fprq2 Times New Roman Tur;}
{\f41\froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\f42\froman\fcharset178\fprq2 Times New Roman (Arabic);}{\f43\froman\fcharset186\fprq2 Times New Roman Baltic;}{\f44\froman\fcharset163\fprq2 Times New Roman (Vietnamese);}
{\f46\fswiss\fcharset238\fprq2 Arial CE;}{\f47\fswiss\fcharset204\fprq2 Arial Cyr;}{\f49\fswiss\fcharset161\fprq2 Arial Greek;}{\f50\fswiss\fcharset162\fprq2 Arial Tur;}{\f51\fswiss\fcharset177\fprq2 Arial (Hebrew);}
{\f52\fswiss\fcharset178\fprq2 Arial (Arabic);}{\f53\fswiss\fcharset186\fprq2 Arial Baltic;}{\f54\fswiss\fcharset163\fprq2 Arial (Vietnamese);}}{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;
\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;
\red192\green192\blue192;}{\stylesheet{\ql \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext0 Normal;}{\*\cs10 \additive \ssemihidden Default Paragraph Font;}{\*
\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\trcbpat1\trcfpat1\tscellwidthfts0\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv 
\ql \li0\ri0\widctlpar\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \fs20\lang1024\langfe1024\cgrid\langnp1024\langfenp1024 \snext11 \ssemihidden Normal Table;}}{\*\latentstyles\lsdstimax156\lsdlockeddef0}{\*\listtable{\list\listtemplateid-164227288
\listsimple{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat3\levelold\levelspace0\levelindent336{\leveltext\'03(\'00);}{\levelnumbers\'02;}\f0\fbias0 }{\listname ;}\listid27144811}{\list\listtemplateid-1609164648\listsimple
{\listlevel\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat2\levelold\levelspace0\levelindent374{\leveltext\'03(\'00);}{\levelnumbers\'02;}\f0\fbias0 }{\listname ;}\listid1611081468}{\list\listtemplateid-999012072\listsimple{\listlevel
\levelnfc4\levelnfcn4\leveljc0\leveljcn0\levelfollow0\levelstartat1\levelold\levelspace0\levelindent360{\leveltext\'03(\'00);}{\levelnumbers\'02;}\f0\fbias0 }{\listname ;}\listid1786000165}}{\*\listoverridetable{\listoverride\listid1611081468
\listoverridecount0\ls1}{\listoverride\listid27144811\listoverridecount0\ls2}{\listoverride\listid1786000165\listoverridecount0\ls3}}{\*\rsidtbl \rsid8718645}{\*\generator Microsoft Word 11.0.5604;}{\info{\title medicross.PDF}{\author TebogoM}
{\operator owner}{\creatim\yr2007\mo6\dy27\hr13\min23}{\revtim\yr2007\mo6\dy27\hr13\min24}{\version2}{\edmins1}{\nofpages29}{\nofwords6762}{\nofchars38545}{\nofcharsws45217}{\vern24689}}\paperw11909\paperh16834\margl1753\margr1795\margb720 
\widowctrl\ftnbj\aenddoc\noxlattoyen\expshrtn\noultrlspc\dntblnsbdb\nospaceforul\hyphcaps0\horzdoc\dghspace120\dgvspace120\dghorigin1701\dgvorigin1984\dghshow0\dgvshow3\jcompress\viewkind1\viewscale120\nolnhtadjtbl\rsidroot8718645 \fet0\sectd 
\sbknone\linex0\colsx60\sectdefaultcl\sftnbj {\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl4
\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}
{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}\pard\plain \ql \li1392\ri0\nowidctlpar\faauto\rin0\lin1392\itap0 \cbpat8 
\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\b\fs24\expnd-1\expndtw-6\insrsid8718645 IN THE COMPETITION APPEAL COURT}{\insrsid8718645 
\par }\pard \ql \li4886\ri0\sb134\sl-792\slmult0\nowidctlpar\faauto\rin0\lin4886\itap0 \cbpat8 {\b\fs24\expnd0\expndtw-4\insrsid8718645 CASE No.: 55/CAC/Sept05}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb5\sl-792\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs24\expnd0\expndtw-3\insrsid8718645 In the matter between:}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sl-792\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-5\insrsid8718645 MEDICROSS HEALTHCARE GROUP}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb14\nowidctlpar\tx6326\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-9\insrsid8718645 (PTY) LTD}{\b\fs24\loch\af1\insrsid8718645 \tab }{\b\fs24\expnd-1\expndtw-6\insrsid8718645 First Appellant}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb120\sl-792\slmult0\nowidctlpar\tx6389\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-7\insrsid8718645 PRIME CURE HOLDINGS (PTY) LTD}{\b\fs24\loch\af1\insrsid8718645 \tab }{\b\fs24\expnd-1\expndtw-5\insrsid8718645 
Second Appellant}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sl-792\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd0\expndtw-3\insrsid8718645 and}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb5\sl-792\slmult0\nowidctlpar\tx6811\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd0\expndtw-3\insrsid8718645 THE COMPETITION COMMISSION}{\b\fs24\loch\af1\insrsid8718645 \tab }{\b\fs24\expnd-1\expndtw-5\insrsid8718645 Respondent}{
\insrsid8718645 
\par }\pard \qc \li0\ri154\sb686\nowidctlpar\faauto\rin154\lin0\itap0 \cbpat8 {\b\fs24\expnd0\expndtw-4\insrsid8718645 JUDGMENT}{\insrsid8718645 
\par }\pard \ql \li0\ri0\nowidctlpar\tlul\tx8016\faauto\rin0\lin0\itap0 \cbpat8 {\fs24\insrsid8718645 \tab }{\insrsid8718645 
\par }\pard \ql \li0\ri5914\sb307\sl-538\slmult0\nowidctlpar\faauto\rin5914\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-6\insrsid8718645 MHLANTLA, AJA: }{\b\fs24\expnd-1\expndtw-8\insrsid8718645 A. INTRODUCTION}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb101\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [1] On 15 September 2005 the Competition Tribunal (\'93the Tribunal\'94) }{\fs28\expnd-1\expndtw-5\insrsid8718645 
prohibited a merger between the first and second appellants on the basis that }{\fs28\expnd0\expndtw-4\insrsid8718645 the said merger was likely to lead to a substantial lessening of competition. }{\fs28\expnd0\expndtw-2\insrsid8718645 
The appellants immediately noted an appeal to this Court against the said }{\fs28\expnd0\expndtw-1\insrsid8718645 decision. The appeal was heard on 7 December 2005. On 31January 2006 }{\fs28\expnd0\expndtw-4\insrsid8718645 
the appeal was upheld. This Court set aside the order of the Tribunal and replaced it with an order that the merger be approved unconditionally. I now }{\fs28\insrsid8718645 set out the reasons for the order.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 2}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb1632\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-5\insrsid8718645 B. FACTUAL BACKGROUND}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb154\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [2] The primary acquiring firm is Medicross Healthcare Group (Pty) Ltd, }{\fs28\expnd0\expndtw-2\insrsid8718645 
the first appellant herein. The shares in the first appellant are owned by }{\fs28\expnd0\expndtw-4\insrsid8718645 Network Healthcare Holdings Limited (80%) and Netpartner Investments }{\fs28\expnd0\expndtw-2\insrsid8718645 
Limited (20%). The primary target firm is Prime Cure Holdings (Pty) Ltd, }{\fs28\insrsid8718645 the second appellant. Its shareholders are Brait Private Equity (34,2%); Praxis Private Equity (29,30%); CDC Financial Services Mauritius Ltd }{
\fs28\expnd0\expndtw-3\insrsid8718645 (11, 3%); Total Support Management (Pty) Ltd (8,22%) and other minority }{\fs28\insrsid8718645 shareholders (16,95%). The first appellant intends to acquire the entire }{\fs28\expnd0\expndtw-3\insrsid8718645 
issued share capital (together with the shareholders\rquote  claim and loan claims against) in the second appellant. The total purchase consideration is R85 }{\fs28\insrsid8718645 million.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [3] On 5 March 2005 the merger was notified to the Competition Commission in terms of section 13A of the Competition Act 89 of 1998 (\'93the Act\'94
) as a large merger. On 30 June 2005 the Commission }{\fs28\expnd0\expndtw-2\insrsid8718645 recommended to the Tribunal that the proposed merger be prohibited. A }{\fs28\expnd0\expndtw-3\insrsid8718645 
hearing before the Tribunal was conducted where various witnesses were }{\fs28\expnd0\expndtw-4\insrsid8718645 called by the appellants, the respondent as well as the Tribunal respectively. }{\fs28\insrsid8718645 
At the end of the hearing the Tribunal concluded that the horizontal }{\fs28\expnd0\expndtw-4\insrsid8718645 dimensions of the merger were likely to lead to a substantial lessening of }{\fs28\insrsid8718645 
competition in the relevant market. It is against this decision that the appellants have appealed to this Court.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 3}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb403\sl-379\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [4] It is apposite at this stage to set out the relevant provisions dealing with }{\fs28\insrsid8718645 
mergers. Section 12A of the Act provides:-}{\fs24\insrsid8718645 \'93(1) Whenever required to consider a merger, the Competition Commission or }{\fs24\expnd0\expndtw-2\insrsid8718645 Competition Tribunal must ini
tially determine whether or not the merger is likely }{\fs24\expnd0\expndtw-1\insrsid8718645 to substantially prevent or lessen competition,  by assessing the factors set out in }{\fs24\insrsid8718645 ss (2); and-}{\fs24\expnd0\expndtw-1\insrsid8718645 
(a) if it appears that the merger is likely to substantially prevent or lessen }{\fs24\insrsid8718645 competition, then determine-}{\fs24\expnd0\expndtw-3\insrsid8718645 (i)    whether   or   not   the   merger   is   likely   to   result   in   any }{
\fs24\expnd0\expndtw-1\insrsid8718645 technological, efficiency or other pro-competitive gain which will}{\insrsid8718645 
\par }\pard \qj \li2098\ri0\sl-264\slmult0\nowidctlpar\faauto\rin0\lin2098\itap0 \cbpat8 {\fs24\insrsid8718645 be}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 greater}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 than}{\i\fs28\insrsid8718645 , }{
\fs24\insrsid8718645 and}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 offset,}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 the}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 effects}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 of}{\fs28\insrsid8718645  
}{\fs24\insrsid8718645 any}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 prevention}{\fs28\insrsid8718645  }{\fs24\insrsid8718645 or }{\fs24\expnd0\expndtw-4\insrsid8718645 lessening of competition, that may result or is likely to result from }{
\fs24\expnd0\expndtw-1\insrsid8718645 the merger, and would not likely be obtained if the merger is }{\fs24\insrsid8718645 prevented; and}{\insrsid8718645 
\par }\pard \qj \li2098\ri0\sb206\sl-269\slmult0\nowidctlpar\faauto\rin0\lin2098\itap0 \cbpat8 {\fs24\expnd0\expndtw-2\insrsid8718645 (ii) whether the merger can or cannot be justified on substantial }{\fs24\insrsid8718645 
public interest grounds by assessing the factors set out in subsection (3); or}{\insrsid8718645 
\par }\pard \qj \fi379\li1109\ri0\sb206\sl-264\slmult0\nowidctlpar\faauto\rin0\lin1109\itap0 \cbpat8 {\fs24\insrsid8718645 
(b) Otherwise, determine whether the merger can or cannot be justified on substantial public interest grounds by assessing the factors set out in subsection (3).}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb206\sl-307\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-1\insrsid8718645 (2) When determining whether or not a merger is likely to substantially prevent }{\fs24\insrsid8718645 or lessen comp
etition, the Competition Commission or Competition Tribunal }{\fs24\expnd0\expndtw-4\insrsid8718645 must assess the strength of competition in the relevant market, and the probability }{\fs24\expnd0\expndtw-3\insrsid8718645 
that the firms in the market after the merger will behave competitively or co\-}{\fs24\expnd0\expndtw-4\insrsid8718645 operatively taking into account any factor that is relevant to competition in that }{\fs24\insrsid8718645 market, including/-}{
\fs24\expnd0\expndtw-2\insrsid8718645 (a) the actual and potential level of import competition in the market;}{\insrsid8718645 
\par {\pntext\pard\plain\hich\af0\dbch\af0\loch\f0 (b)\tab}}\pard \ql \li1392\ri0\sl-254\slmult0\nowidctlpar\tx1766{\*\pn \pnlvlbody\ilvl0\ls1\pnrnot0\pnlcltr\pnstart2\pnindent374 {\pntxtb (}{\pntxta )}}\faauto\ls1\rin0\lin1392\itap0\pararsid8718645 \cbpat8 {
\fs24\insrsid8718645 the ease of entry into the market, including the tariff and regulatory barriers;}{\fs24\expnd-1\expndtw-5\insrsid8718645 
\par {\pntext\pard\plain\expnd0\expndtw-1 \hich\af0\dbch\af0\loch\f0 (c)\tab}}\pard \ql \li1392\ri0\sl-259\slmult0\nowidctlpar\tx1766{\*\pn \pnlvlbody\ilvl0\ls1\pnrnot0\pnlcltr\pnstart2\pnindent374 {\pntxtb (}{\pntxta )}}
\faauto\ls1\rin0\lin1392\itap0\pararsid8718645 \cbpat8 {\fs24\expnd0\expndtw-1\insrsid8718645 the level and trends of concentration, and history of collusion, in the }{\fs24\insrsid8718645 market;}{\fs24\expnd-1\expndtw-7\insrsid8718645 
\par {\pntext\pard\plain\expnd0\expndtw-3 \hich\af0\dbch\af0\loch\f0 (d)\tab}}{\fs24\expnd0\expndtw-3\insrsid8718645 the degree of countervailing power in the market;}{\fs24\expnd-1\expndtw-5\insrsid8718645 
\par }\pard \ql \li1454\ri998\sl-259\slmult0\nowidctlpar\tx1728\faauto\rin998\lin1454\itap0 \cbpat8 {\fs24\expnd-1\expndtw-7\insrsid8718645 (e)}{\fs24\insrsid8718645 \tab }{\fs24\expnd-1\expndtw-5\insrsid8718645 
the dynamic characteristics of the market, including growth,\line }{\fs24\insrsid8718645 innovation, and product differentiation;}{\insrsid8718645 
\par }\pard \ql \li1392\ri0\sl-259\slmult0\nowidctlpar\tx1728\faauto\rin0\lin1392\itap0 \cbpat8 {\fs24\expnd-2\expndtw-14\insrsid8718645 (f)}{\fs24\insrsid8718645 \tab }{\fs24\expnd0\expndtw-3\insrsid8718645 
the nature and extent of vertical integration in the market;}{\insrsid8718645 
\par }\pard \ql \fi120\li1229\ri0\sl-259\slmult0\nowidctlpar\tx1675\faauto\rin0\lin1229\itap0 \cbpat8 {\fs24\expnd-1\expndtw-6\insrsid8718645 (g)}{\fs24\insrsid8718645 \tab }{\fs24\expnd0\expndtw-4\insrsid8718645 
whether the business or part of the business of a party to the merger   or\line }{\fs24\insrsid8718645 proposed merger has failed or is likely to fail; and}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 4}{\insrsid8718645 
\par }\pard \ql \li1406\ri0\sb432\sl-254\slmult0\nowidctlpar\faauto\rin0\lin1406\itap0 \cbpat8 {\fs24\insrsid8718645 (h) whether  the merger will result in the removal of an effective competitor.}{\insrsid8718645 
\par }\pard \ql \li706\ri0\sb178\sl-350\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\insrsid8718645 
(3)   When determining whether a merger can or cannot be justified on public interest grounds, the Competition Commission or Competition Tribunal must consider the effect that the merger will have on:-(a) a particular industrial sector or region;}{
\insrsid8718645 
\par }\pard \ql \li1392\ri0\sl-269\slmult0\nowidctlpar\tx1723\faauto\rin0\lin1392\itap0 \cbpat8 {\fs24\expnd-1\expndtw-6\insrsid8718645 (b)}{\fs24\insrsid8718645 \tab }{\fs24\expnd-1\expndtw-5\insrsid8718645 employment;}{\insrsid8718645 
\par {\pntext\pard\plain\hich\af0\dbch\af0\loch\f0 (c)\tab}}\pard \ql \li1392\ri0\sl-269\slmult0\nowidctlpar\tx1728{\*\pn \pnlvlbody\ilvl0\ls2\pnrnot0\pnlcltr\pnstart3\pnindent336 {\pntxtb (}{\pntxta )}}\faauto\ls2\rin0\lin1392\itap0\pararsid8718645 \cbpat8 {
\fs24\insrsid8718645 the ability of small businesses, or firms controlled or owned by }{\fs24\expnd0\expndtw-3\insrsid8718645 historically disadvantaged persons, to become competitive}{\i\fs24\expnd0\expndtw-3\insrsid8718645 ; }{
\fs24\expnd0\expndtw-3\insrsid8718645 and}{\fs24\expnd-1\expndtw-7\insrsid8718645 
\par {\pntext\pard\plain\expnd0\expndtw-3 \hich\af0\dbch\af0\loch\f0 (d)\tab}}{\fs24\expnd0\expndtw-3\insrsid8718645 the ability of national industries to compete in international markets.}{\fs24\expnd-1\expndtw-6\insrsid8718645 
\par }\pard \ql \li0\ri0\sb466\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd-2\expndtw-13\insrsid8718645 C. }{\b\fs24\ul\expnd0\expndtw-4\insrsid8718645 RECOMMENDATIONS}{\b\fs28\ul\expnd0\expndtw-4\insrsid8718645  }{
\b\fs24\ul\expnd0\expndtw-4\insrsid8718645 OF}{\b\fs28\ul\expnd0\expndtw-4\insrsid8718645  }{\b\fs24\ul\expnd0\expndtw-4\insrsid8718645 THE}{\b\fs28\ul\expnd0\expndtw-4\insrsid8718645  }{\b\fs24\ul\expnd0\expndtw-4\insrsid8718645 RESPONDENT.}{
\insrsid8718645 
\par }\pard \qj \li0\ri0\sb259\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [5] After analysing the submissions by the parties as well as additional }{\fs28\expnd0\expndtw-3\insrsid8718645 
information, the respondent identified only three firms that were competing }{\fs28\expnd0\expndtw-1\insrsid8718645 in the market for managed care services that have a national network of }{\fs28\expnd0\expndtw-3\insrsid8718645 
service providers namely, Prime Cure, Medicross and Carecross. It did not }{\fs28\expnd0\expndtw-2\insrsid8718645 support the parties\rquote  contention of the existence of other players and their }{\fs28\insrsid8718645 
ability to enter the market with ease.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [6] The 
respondent found that the proposed merger would strengthen the Netcare group and will reduce the number of players from three to two. }{\fs28\expnd0\expndtw-1\insrsid8718645 According to the respondent the proposed merger would significantly }{
\fs28\insrsid8718645 concentrate the market for the provision of managed care services and }{\fs28\expnd0\expndtw-3\insrsid8718645 eliminate a likely potential entrant into the bottom segment of the market. }{\fs28\insrsid8718645 
This would reduce the choice of medical aid schemes to enter into capitation agreements with managed care companies. The respondent concluded thus:}{\insrsid8718645 
\par }\pard \ql \li706\ri0\sb216\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\insrsid8718645 \'93[T]he market in which the parties compete is highly concentrated. }{\fs28\expnd0\expndtw-1\insrsid8718645 
The barriers to entry into this market are immensely challenging and}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 5}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 according to Prime Cure extremely high. Sustainable and successful }{\fs28\insrsid8718645 
market participants are few and far between. According to the }{\fs28\expnd0\expndtw-3\insrsid8718645 Commission the likely entry into the market by other firms are highly speculative and unlikely to occur. Considering all of the above the }{
\fs28\insrsid8718645 Commission is of the view that the transaction is likely to }{\fs28\expnd0\expndtw-4\insrsid8718645 substantially prevent or lessen competition in the manager healthcare market with a national network of service providers.\'94}{
\insrsid8718645 
\par }\pard \ql \li0\ri0\sb317\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [7] The respondent went on to say:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb283\sl-461\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\insrsid8718645 \'93Furthermore, the Commission is of the view that the transaction }{\fs28\expnd0\expndtw-4\insrsid8718645 raises significant public in
terest concerns relating to the industry as a }{\fs28\expnd0\expndtw-3\insrsid8718645 whole and the effect that the transaction is likely to have on small }{\fs28\expnd0\expndtw-1\insrsid8718645 
business and businesses controlled by historically disadvantaged }{\fs28\insrsid8718645 persons.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [8] The respondent then considered the efficiency defences raised by }{\fs28\expnd0\expndtw-4\insrsid8718645 
appellants. It concluded that these did not outweigh the effects of the likely prevention or lessening of competition. It also considered the public interest }{\fs28\expnd0\expndtw-2\insrsid8718645 
issues and concluded that the transaction could not be justified on public }{\fs28\insrsid8718645 interest grounds .}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb346\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [9] The respondent thus recommended that the merger be prohibited.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 6}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb418\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd-2\expndtw-14\insrsid8718645 D. }{\b\fs24\ul\expnd-1\expndtw-5\insrsid8718645 FINDINGS}{\b\fs28\ul\expnd-1\expndtw-5\insrsid8718645  }{
\b\fs24\ul\expnd-1\expndtw-5\insrsid8718645 OF}{\b\fs28\ul\expnd-1\expndtw-5\insrsid8718645  }{\b\fs24\ul\expnd-1\expndtw-5\insrsid8718645 THE}{\b\fs28\ul\expnd-1\expndtw-5\insrsid8718645  }{\b\fs24\ul\expnd-1\expndtw-5\insrsid8718645 TRIBUNAL}{
\insrsid8718645 
\par }\pard \qj \li0\ri0\sb254\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [10] It has not proved easy to isolate the essential reasoning upon which the }{\fs28\insrsid8718645 Tribunal\rquote 
s determination is predicated. The following summary seeks to }{\fs28\expnd0\expndtw-3\insrsid8718645 read its key findings in the best possible light. The Tribunal commenced its }{\fs28\expnd0\expndtw-4\insrsid8718645 
determination of whether the merger was likely to substantially prevent or lessen competition (s 12A (2)(e) of the Act) with an analysis of the \'93general state of healthcare provisioning in South Africa the policy objectives of the }{
\fs28\insrsid8718645 South African government in the realm of healthcare provision, the }{\fs28\expnd-1\expndtw-5\insrsid8718645 mechanisms whereby government intends achieving those objectives and the }{\fs28\expnd0\expndtw-3\insrsid8718645 
place and role of the private section\'85\'94.(para 51). It concluded its analysis }{\fs28\insrsid8718645 thus:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb710\sl-398\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\insrsid8718645 \'93 It is our view then, that in this extremely fluid context , the absence of an }{\fs24\expnd0\expndtw-4\insrsid8718645 
established and stable regulatory framework for this embryonic market as well as }{\fs24\insrsid8718645 for some related and long-standing markets (for example, pharmaceuticals) demands that we adopt a particularly cautious and circumspect approach to }{
\fs24\expnd0\expndtw-2\insrsid8718645 private interventions, such as this merger, that will inevitably impact on the }{\fs24\expnd0\expndtw-4\insrsid8718645 development of the market under consideration. Public interest considerations }{
\fs24\expnd0\expndtw-2\insrsid8718645 impinging on the outcome of interventions in this area- be they interventions by }{\fs24\expnd0\expndtw-3\insrsid8718645 the State, by regulators or by private market participants- are, for unimpeachably }{
\fs24\insrsid8718645 good reason unusually intense and this also predisposes us to particular circumspection.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb379\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [11] The Tribunal found that the relevant product market was that for the }{\fs28\expnd-1\expndtw-5\insrsid8718645 
provision of capitated primary managed health care products with a national }{\fs28\insrsid8718645 geographic market. The definition of capitated managed primary care }{\fs28\expnd0\expndtw-3\insrsid8718645 employed by the Tribunal was  \'93
a method of payment for health services in}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 7}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 which a provider is paid a fixed, per capita, amount in advance for each }{\fs28\expnd0\expndtw-3\insrsid8718645 
enrolee without regards to the actual number of nature of services provided }{\fs28\expnd0\expndtw-4\insrsid8718645 to each member in advance. This involves a great deal of risk sharing\'94 (para }{\fs28\insrsid8718645 109)}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb461\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [12] The Tribunal thereafter examined the impact of the merger on }{\fs28\expnd0\expndtw-2\insrsid8718645 
competition and found that the horizontal dimensions of the merger were }{\fs28\insrsid8718645 likely to lead to a substantial lessening of competition in the relevant }{\fs28\expnd0\expndtw-4\insrsid8718645 market.
 In particular, it held that the barriers to entry were formidable. The }{\fs28\expnd0\expndtw-1\insrsid8718645 
merger would serve to increase concentration, and in effect reducing the three viable competitors to two, being first and second appella nts and }{\fs28\expnd0\expndtw-2\insrsid8718645 Carecross. Accordingly, the Tribunal found that \'93
the removal of a rival \endash  Prime Cure \endash  to Netdirect and Medicross, increases the likelihood of a }{\fs28\expnd0\expndtw-4\insrsid8718645 
relationship between Netcare, on the one hand, and Mediclinic and Life Healthcare on the other and certainly aggravates our concerns regarding the }{\fs28\expnd0\expndtw-3\insrsid8718645 future state of competition in a vital related healthcare market\'94
. (para 188). }{\fs28\expnd-1\expndtw-5\insrsid8718645 The Tribunal went on to hold that the merger stood to be prohibited on its horizontal dimensions which were likely to lead to a substantial lessening of }{\fs28\insrsid8718645 
competition in the relevant market. It found however that there was insufficient evidence to establish that \lquote the vertical integration that }{\fs28\expnd0\expndtw-2\insrsid8718645 
characterises Netcare distorted referrel patterns were sufficient to justify a }{\fs28\insrsid8718645 conclusion that a substantial lessening, of competition would occur on vertical grounds.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [13] The Tribunal prohibited the merger, having found that the claimed }{\fs28\expnd0\expndtw-1\insrsid8718645 
efficiency grounds did not outweigh the costs competitive effects of the }{\fs28\insrsid8718645 merger.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs26\insrsid8718645 8}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb413\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 E}{\b\fs24\expnd0\expndtw-3\insrsid8718645 .}{\b\fs28\expnd0\expndtw-3\insrsid8718645  }{\b\fs24\ul\expnd0\expndtw-3\insrsid8718645 SUBMISSIONS}{
\b\fs28\ul\expnd0\expndtw-3\insrsid8718645  }{\b\fs24\ul\expnd0\expndtw-3\insrsid8718645 BY}{\b\fs28\ul\expnd0\expndtw-3\insrsid8718645  }{\b\fs24\ul\expnd0\expndtw-3\insrsid8718645 THE}{\b\fs28\ul\expnd0\expndtw-3\insrsid8718645  }{
\b\fs24\ul\expnd0\expndtw-3\insrsid8718645 PARTIES.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb254\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [14] At the hearing of the appeal, }{\fs28\ul\expnd0\expndtw-4\insrsid8718645 Mr Unterhalter,}{
\fs28\expnd0\expndtw-4\insrsid8718645  who appeared with }{\fs28\ul\expnd0\expndtw-4\insrsid8718645 Mr Cockrell}{\fs28\expnd0\expndtw-4\insrsid8718645  for the appellants, submitted that the Tribunal misdirected itself in }{
\fs28\expnd0\expndtw-2\insrsid8718645 that it adopted a \'93cautious and circumspect approach\'94 to the merger; that is }{\fs28\insrsid8718645 it had conflated public interest grounds with its primary
 task, that is an enquiry as to whether there was a likelihood that the merger would substantially lessen competition.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb941\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [15] Mr Unterhalter contended that the misdirection vitiated the Tribunal\rquote s }{\fs28\expnd0\expndtw-3\insrsid8718645 
decision and that the appeal should succeed. He submitted that there was no }{\fs28\expnd0\expndtw-2\insrsid8718645 textual support in the Act for a conflation of public interest considerations }{\fs28\expnd0\expndtw-4\insrsid8718645 
with the predictive task mandated by the Act. He contended that the need to }{\fs28\expnd0\expndtw-1\insrsid8718645 consider \'93public interest grounds\'94 comprises a separate and subsequent }{\fs28\insrsid8718645 enquiry to the p
rimary determination as to whether or not the relevant }{\fs28\expnd0\expndtw-4\insrsid8718645 merger is likely to substantially prevent or lessen competition. Referring to }{\fs28\insrsid8718645 paragraph 71 of the Tribunal\rquote 
s reasons where it was stated that \'93public interest considerations\'94 predisposed the Tribunal to particular }{\fs28\expnd-1\expndtw-5\insrsid8718645 circumspection when considering this merger, he submitted that the Tribunal }{
\fs28\expnd0\expndtw-3\insrsid8718645 at no stage had proceeded to a detailed \'93second order analysis\'94 in order to }{\fs28\insrsid8718645 consider whether the merger could or could not be justified on public }{\fs28\expnd0\expndtw-4\insrsid8718645 
interest grounds within the meaning of section 12A(3) of the Act. On the }{\fs28\expnd-1\expndtw-5\insrsid8718645 contrary, the Tribunal had regard to public interest considerations }{\i\fs28\expnd-1\expndtw-5\insrsid8718645 at the first }{
\i\fs28\insrsid8718645 stage of analysis }{\fs28\insrsid8718645 for the purposes of determining whether the merger is like ly to substantially prevent or lessen competition.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 9}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb1022\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd-1\expndtw-5\insrsid8718645 
[16] Mr Unterhalter further contended that the public interest grounds which the Tribunal purported to consider in its determination did not fall within the }{\fs28\insrsid8718645 ambit of sectio n 12A(3). The Tribunal had noted \'93Pertinent to our }{
\fs28\expnd-1\expndtw-5\insrsid8718645 consideration of the general state of healthcare provisioning in South Africa, }{\fs28\insrsid8718645 the policy objectives of the South African government in the realm of healthcare provision, the mechanisms whe
reby government intends }{\fs28\expnd0\expndtw-2\insrsid8718645 achieving those objectives, and the place and role of the private sector, }{\fs28\expnd0\expndtw-1\insrsid8718645 including the merging parties and many others who participate in these }{
\fs28\expnd0\expndtw-4\insrsid8718645 hearings, in this wider context\'94 (para 51). Mr Unterhalter submitted that the }{\fs28\expnd0\expndtw-3\insrsid8718645 public interest concerns which appear to have coloured this approach were }{
\fs28\expnd-1\expndtw-5\insrsid8718645 not concerns which the Tribunal was mandated to consider at this stage of its }{\fs28\insrsid8718645 enquiry. The mechanisms by which Government intends to achieve its policy objectives and the place and role of th
e private sector in these }{\fs28\expnd0\expndtw-4\insrsid8718645 objectives are issues which fall within the purview of Parliament and the Executive; they are not issues that fall within the remit of the competition }{\fs28\insrsid8718645 authorities.}{
\insrsid8718645 
\par }\pard \qj \li0\ri5\sb235\sl-466\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 [17] }{\fs28\ul\expnd0\expndtw-1\insrsid8718645 Mr Berger,}{\fs28\expnd0\expndtw-1\insrsid8718645 
 who appeared on behalf of the respondent, submitted that }{\fs28\expnd0\expndtw-3\insrsid8718645 the Tribunal had conducted a careful and detailed analysis of the evidence. }{\fs28\expnd0\expndtw-4\insrsid8718645 
The Tribunal did not purport to adopt an approach that assessed whether the merger was likely to substantially prevent or lessen competition against the factors set out in s
ection 12A(3) of the Act or any other public interest considerations. He thus contended that no misdirection had been committed }{\fs28\insrsid8718645 by the Tribunal, alternatively; if such misdirection was found,   this Court}{\insrsid8718645 
\par \sect }\sectd \margrsxn1761\linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri29\nowidctlpar\faauto\rin29\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\expnd0\expndtw-2\insrsid8718645 10}{\insrsid8718645 

\par }\pard \qj \li0\ri43\sb341\sl-461\slmult0\nowidctlpar\faauto\rin43\lin0\itap0 \cbpat8 {\fs28\expnd-1\expndtw-5\insrsid8718645 ought to assess the evidence placed before the Tribunal and make an order in }{\fs28\insrsid8718645 
terms of section 17(2) and/or section 17(3) of the Act.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [18] Accordingly the question arises as to the proper approach to the }{\fs28\expnd0\expndtw-1\insrsid8718645 
enquiry mandated by s 12A of the Act. In }{\fs28\ul\expnd0\expndtw-1\insrsid8718645 Schuman Sasol SA (Pty) Ltd v }{\fs28\ul\expnd-1\expndtw-5\insrsid8718645 Price\rquote s Daelite (Pty) Ltd [2001-2002] CPLR 84 (CAC) at 90d}{
\fs28\expnd-1\expndtw-5\insrsid8718645  this Court said }{\fs28\insrsid8718645 the following:}{\insrsid8718645 
\par }\pard \qj \li706\ri34\sb240\sl-398\slmult0\nowidctlpar\faauto\rin34\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-4\insrsid8718645 \'93The approach which this Court adopts to an appeal against the decision of the }{\fs24\expnd0\expndtw-1\insrsid8718645 
Tribunal in respect of a merger should take cognisance of the composition and role of the Tribunal as a specialist body which consists not only of lawyers but }{\fs24\expnd0\expndtw-2\insrsid8718645 
also of members possessed of the necessary financial and economic knowledge }{\fs24\insrsid8718645 and thorough grasp of the relevant policy issues required in these kind of }{\fs24\expnd0\expndtw-4\insrsid8718645 
deliberations. Section 12A requires that the Tribunal make a determination after a holistic inquiry into whether the proposed merger is likely to substantially prevent }{\fs24\insrsid8718645 
or lessen competition. In assessing such a decision, this Court should take }{\fs24\expnd0\expndtw-3\insrsid8718645 account of the composition and expertise of the Tribunal as well as the nature of }{\fs24\expnd0\expndtw-2\insrsid8718645 
the enquiry which entails an element of probabilistic investigation into the effect}{\insrsid8718645 
\par }\pard \ql \li706\ri0\sl-398\slmult0\nowidctlpar\tldot\tx3221\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-2\insrsid8718645 of the proposed merger }{\fs24\insrsid8718645 \tab   In its decision as to whether to set aside, amend or}{
\insrsid8718645 
\par }\pard \ql \li706\ri0\sl-398\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\insrsid8718645 
confirm  the  decision  of  the  Tribunal, this   Court must be cautious before imposing   its own conception of the policy considerations upon the decision adopted by the Tribunal . The Court should   seek rather to examine and test rigorously the justif
ications offered by the Tribunal for the decision to which it }{\fs24\expnd0\expndtw-2\insrsid8718645 has arrived before it invokes its power in terms of section 17.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri34\sb216\sl-466\slmult0\nowidctlpar\faauto\rin34\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 This }{\b\fs28\expnd0\expndtw-3\insrsid8718645 dictum }{\fs28\expnd0\expndtw-3\insrsid8718645 
made it clear that this Court recognizes the expertise of the }{\fs28\insrsid8718645 Tribunal with regard to the evaluation of economic evidence and the }{\fs28\expnd-1\expndtw-5\insrsid8718645 
development of a sound policy framework which informs this evaluation. }{\fs28\expnd0\expndtw-1\insrsid8718645 However, recognition of the specialist role of the Tribunal does not mean }{\fs28\insrsid8718645 
that the Court should not test whether the evidence led can justify the}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 11}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb341\sl-461\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 conclusion reached by the Tribunal nor should this Court be deferential to }{\fs28\expnd0\expndtw-1\insrsid8718645 
the manner in which the Tribunal engages with the interpretation of the }{\fs28\insrsid8718645 structure of the Act or the mandated legislative tests.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [19] Within the context of mergers, section 12A provides for a two stage }{\fs28\expnd0\expndtw-4\insrsid8718645 
analysis. The first phase involves the determination by the Tribunal whether }{\fs28\expnd0\expndtw-3\insrsid8718645 the merger is likely to substantially lessen or prevent competition, having }{\fs28\expnd0\expndtw-2\insrsid8718645 
regard to the evidence and argument presented before it by the respondent }{\fs28\expnd0\expndtw-4\insrsid8718645 and the parties. The inquiry is conducted by assessing the factors set out in }{\fs28\insrsid8718645 
section 12A(2). The word likely has its prime meaning of \'93probability\'94 }{\fs28\expnd0\expndtw-3\insrsid8718645 whilst the word \'93substantially\'94 means materially or considerably in amount }{\fs28\insrsid8718645 or duration.}{\insrsid8718645 

\par }\pard \qj \li0\ri0\sb230\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [20] The manner in which the Tribunal justifies its finding on the evidence }{\fs28\insrsid8718645 
before it is of critical importance. In }{\fs28\ul\insrsid8718645 Mondi Ltd and Kohler Cores and }{\fs28\ul\expnd0\expndtw-2\insrsid8718645 Tubes v Competition Tribunal [2003] 1 CPLR 25 (CAC) at 33c}{\fs28\expnd0\expndtw-2\insrsid8718645 , this court }{
\fs28\insrsid8718645 said:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb221\sl-403\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-3\insrsid8718645 \'93 The decision required by section 12A(1) must be made on evidence which is }{\fs24\expnd0\expndtw-1\insrsid8718645 
available to the Tribunal. In other words the Tribunal cannot base its decision }{\fs24\expnd-1\expndtw-5\insrsid8718645 upon speculation of a kind which cannot be attributed to any evidential foundation }{\fs24\expnd0\expndtw-1\insrsid8718645 
placed before the Tribunal. But the prohibition against unjustified speculation }{\fs24\insrsid8718645 should not be confused with the need for a predictive judgment. The section }{\fs24\expnd0\expndtw-2\insrsid8718645 
enjoins the Tribunal to forecast a likely possibly, that is, it makes a predictive }{\fs24\expnd0\expndtw-3\insrsid8718645 judgment, based on evidence which has been placed before it.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [21] It follows therefore that if the Tribunal finds on the evidence available }{\fs28\insrsid8718645 
that   the   merger   is   capable   of   having   the   anti-competitive   effect}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 12}{\insrsid8718645 
\par }\pard \qj \li0\ri5\sb341\sl-461\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd-1\expndtw-5\insrsid8718645 contemplated, the test would have been satisfied. However, the Tribunal can }{\fs28\expnd0\expndtw-4\insrsid8718645 
only move to the second stage after it has made this finding.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [22]In the present case, the Tribunal adopted a \'93cautious and circumspect\'94 }{\fs28\expnd0\expndtw-2\insrsid8718645 
approach based, to a considerable extent, on public interest considerations. }{\fs28\insrsid8718645 As the Tribunal observed:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 \'93we are, to state the obvious, dealing with a transaction in a market }{\fs28\expnd0\expndtw-3\insrsid8718645 
that is central to the interests of the state, to the private sector and to }{\fs28\expnd0\expndtw-1\insrsid8718645 ordinary consumers. It may well be that in a year\rquote s time, or, more }{\fs28\insrsid8718645 likely, in five years\rquote 
 time, the regulatory framework and the }{\fs28\expnd-1\expndtw-5\insrsid8718645 parameters of the markets implicated in this transaction will be more certain and that the consideration of an identical or similar transaction }{\fs28\insrsid8718645 
will produce a different outcome. However, it is in the nature of }{\fs28\expnd0\expndtw-3\insrsid8718645 merger analysis that changing eras and contexts produce different outcomes. There is no single answer that stands for all time\'94 (at para }{
\fs28\insrsid8718645 72).}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [23] It is extremely difficult to determine the weight which the Tribunal }{\fs28\expnd0\expndtw-2\insrsid8718645 
gave to these public interest grounds. in its probabilistic enquiry. But, as I }{\fs28\expnd0\expndtw-4\insrsid8718645 have already said, these issues should have been of no relevance to the first }{\fs28\expnd0\expndtw-2\insrsid8718645 
stage of its enquiry which needed to examine the evidence relating to the }{\fs28\insrsid8718645 proposed merger\rquote s impact upon competition. These public interest }{\fs28\expnd0\expndtw-4\insrsid8718645 
considerations would have been more appropriately considered during the }{\fs28\insrsid8718645 second phase in terms of section 12A(3), as the need to consider public }{\fs28\expnd-1\expndtw-5\insrsid8718645 
interest grounds is a separate and subsequent enquiry to that of the primary }{\fs28\insrsid8718645 determination.}{\insrsid8718645 
\par \sect }\sectd \margrsxn1781\linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li0\ri10\nowidctlpar\faauto\rin10\lin0\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 13}{\insrsid8718645 
\par }\pard \qj \li0\ri14\sb336\sl-466\slmult0\nowidctlpar\faauto\rin14\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [24] In the result, the Tribunal misdirected itself by adopting an incorrect t}{\fs28\insrsid8718645 est when assessing the evidence}{
\fs28\insrsid8718645 . It failed to engage fully with the }{\fs28\expnd0\expndtw-1\insrsid8718645 probabilistic enquiry of the evidence presented before it. It failed to apply }{\fs28\insrsid8718645 the test set out in section 12
A(1) and (2) before considering the public }{\fs28\expnd0\expndtw-1\insrsid8718645 interest grounds. In the result, this Court is at large to assess the evidence that was placed before the Tribunal and make an order in terms of section }{
\fs28\insrsid8718645 17 of the Act. It is to that evidence that I now turn.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb317\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs28\expnd0\expndtw-4\insrsid8718645 Definition of the relevant market}{\insrsid8718645 
\par }\pard \qj \li0\ri5\sb278\sl-466\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [25] The assessment of the effects of the merger on competition must be }{\fs28\expnd-1\expndtw-5\insrsid8718645 
preceded by a proper definition of the relevant market. The need for market analysis must be viewed within the context of the S 12A(1) of the Act which }{\fs28\expnd0\expndtw-4\insrsid8718645 uses the phrase \lquote 
likely to substantially present or lessen competition\rquote  In this }{\fs28\expnd0\expndtw-2\insrsid8718645 case, the Tribunal found that there would be a \lquote lessening of competition\rquote . }{\fs28\expnd0\expndtw-3\insrsid8718645 
Such a conclusion requires a full market analysis. By contrast, \lquote preventing }{\fs28\expnd0\expndtw-4\insrsid8718645 competition appears to co
ncern impediments or hindrances which retard or keep back that which might otherwise have happened. An enquiry about }{\fs28\expnd0\expndtw-3\insrsid8718645 
impediments may well have allowed the Tribunal to escape an engagement with a comprehensive market analysis. However its finding was based on a }{\fs28\expnd-1\expndtw-5\insrsid8718645 
lessening of competition; hence an analysis of the market is essential to this }{\fs28\insrsid8718645 enquiry.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb917\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [26]There is a dispute between the parties in regard to the definition of the }{\fs28\expnd0\expndtw-1\insrsid8718645 
market. The Tribunal found that the relevant product market is the market }{\fs28\insrsid8718645 for the provision of capitated  primary managed healthcare products.    }{\fs28\ul\insrsid8718645 Mr}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 14}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\ul\expnd-1\expndtw-5\insrsid8718645 Unterhalter}{\fs28\expnd-1\expndtw-5\insrsid8718645 
 submitted that the Tribunal restricted the market definition to the provision of capitated primary managed health care products and failed to }{\fs28\insrsid8718645 recognise that a 
number of other primary managed care options are substitutable for managed care options . He contended that the Tribunal }{\fs28\expnd0\expndtw-3\insrsid8718645 ought to have found that the relevant market is the market for the provision }{
\fs28\expnd0\expndtw-4\insrsid8718645 of primary managed healthcare products for low cost medical schemes, }{\fs28\expnd0\expndtw-3\insrsid8718645 irrespective of whether or not the products are capitated. }{\fs28\ul\expnd0\expndtw-3\insrsid8718645 
Mr Berger}{\fs28\expnd0\expndtw-3\insrsid8718645  on the }{\fs28\expnd-1\expndtw-5\insrsid8718645 other hand argued that the focus ought to be on the contractual arrangements }{\fs28\expnd0\expndtw-1\insrsid8718645 
between managed care organisations and medical schemes when defining }{\fs28\insrsid8718645 the relevant market.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [27] It is apposite at this stage to provide a brief overview of the medical }{\fs28\insrsid8718645 
schemes environment before determining the definition of the relevant market.}{\insrsid8718645 
\par }\pard \qj \li0\ri5\sb254\sl-461\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 [28] Regulations made in terms of the Medical Schemes Act 131 of 1998 }{\fs28\expnd0\expndtw-4\insrsid8718645 (the \'93
Medical Schemes Act\'94) make provision for managed health care. }{\fs28\insrsid8718645 Regulation 15 defines managed health care as:-}{\fs24\expnd0\expndtw-4\insrsid8718645 \'93
 Clinical or financial risk assessment and management of health care with a view }{\fs24\expnd0\expndtw-2\insrsid8718645 to facilitating appropriateness and cost effectiveness of relevant health services }{\fs24\expnd0\expndtw-3\insrsid8718645 within the
 constraints of what is affordable, through the use of rules based and }{\fs24\insrsid8718645 clinical management based programmes.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri5\sb206\sl-466\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [29] A health care provider concludes a contract with a medical scheme in }{\fs28\expnd0\expndtw-4\insrsid8718645 
terms of Regulation 15A and undertakes to provide a relevant health service }{\fs28\expnd0\expndtw-3\insrsid8718645 to the beneficiaries of the medical scheme concerned. There are two sorts of managed health care arrangements envisaged by the Regulations:
}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 15}{\insrsid8718645 
\par {\pntext\pard\plain\fs28\expnd0\expndtw-1 \hich\af0\dbch\af0\loch\f0 (a)\tab}}\pard \qj \li0\ri0\sb432\sl-307\slmult0\nowidctlpar\tx360{\*\pn \pnlvlbody\ilvl0\ls3\pnrnot0\pnlcltr\pnstart1\pnindent360 {\pntxtb (}{\pntxta )}}
\faauto\ls3\rin0\lin0\itap0\pararsid8718645 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 the medical scheme may choose to render managed healthcare to its }{\fs28\expnd0\expndtw-2\insrsid8718645 member \'93 in house\'94
 in which case the medical scheme (or administration) }{\fs28\insrsid8718645 will enter into contractual arrangements directly with a network of participating health care providers.}{\fs28\expnd-1\expndtw-7\insrsid8718645 
\par {\pntext\pard\plain\fs28 \hich\af0\dbch\af0\loch\f0 (b)\tab}}\pard \qj \li0\ri0\sl-307\slmult0\nowidctlpar\tx360{\*\pn \pnlvlbody\ilvl0\ls3\pnrnot0\pnlcltr\pnstart1\pnindent360 {\pntxtb (}{\pntxta )}}\faauto\ls3\rin0\lin0\itap0\pararsid8718645 \cbpat8 {
\fs28\insrsid8718645 A medical scheme may choose to outsource the provision of its members\rquote  managed healthcare.\'94 In this case the scheme enters into a }{\fs28\expnd0\expndtw-4\insrsid8718645 
contractual arrangement with a managed healthcare organisation. The latter then enters into contractual arrangements with a network of participating }{\fs28\insrsid8718645 healthcare providers.}{\fs28\expnd-1\expndtw-8\insrsid8718645 
\par }\pard \qj \li0\ri0\sb106\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [30] The proper approach to the definition of a market is set out by Brassey }{\i\fs28\insrsid8718645 et al}{\fs28\insrsid8718645 
, Competition Law (2002) at 183 thus:}{\insrsid8718645 
\par }\pard \qr \li422\ri0\sb240\sl-418\slmult0\nowidctlpar\faauto\rin0\lin422\itap0 \cbpat8 {\fs24\insrsid8718645 \'93 The market does not define itself\'85... The approach that is ordinarily adopted }{\fs24\expnd-1\expndtw-5\insrsid8718645 
by   economists   to   define   the   market   is   the   hypothetical   monopolist   test, }{\fs24\expnd0\expndtw-1\insrsid8718645 [commonly known as the SSNIP test] which is of a piece with the  definition of }{\fs24\expnd0\expndtw-4\insrsid8718645 
the market in merger control.  The relevant market is best defined according to the 1992 United States Department of Justice Guidelines as follows:-}{\fs24\expnd0\expndtw-3\insrsid8718645 \lquote  A market is defined as a product or 
group of products and a geographical }{\fs24\insrsid8718645 area in which it is produced or sold such that a hypothetical profit-}{\fs24\expnd0\expndtw-2\insrsid8718645 maximising firm, not subject to price regulation, that was the only present }{
\fs24\insrsid8718645 and future producer or seller of those products in that area, likely would impose at least a \'93small but significant and non-transitory\'94 increase in price, assuming the terms of the sale of all other products are held constant.
\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri10\sb216\sl-408\slmult0\nowidctlpar\faauto\rin10\lin0\itap0 \cbpat8 {\b\fs24\expnd0\expndtw-4\insrsid8718645 Massimo Motta Competition Policy: Theory & Practice }{\fs24\expnd0\expndtw-4\insrsid8718645 (2004) at 102-103 provides a }{
\fs24\insrsid8718645 useful example of the SSNIP test:}{\insrsid8718645 
\par }\pard \qj \li706\ri19\sb221\sl-403\slmult0\nowidctlpar\faauto\rin19\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-2\insrsid8718645 \'93Suppose that there exists a hypothetical monopolist that is the only seller of }{\fs24\insrsid8718645 
bananas. Would this hypothetical monopolist find it profitable to increase the }{\fs24\expnd0\expndtw-3\insrsid8718645 price of bananas above the }{\i\fs24\expnd0\expndtw-3\insrsid8718645 current }{\fs24\expnd0\expndtw-3\insrsid8718645 
level in a non-transitory way, say by 5-10% }{\fs24\insrsid8718645 Imagine that the answer to this question is yes, that such a price rise would be}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 16}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb346\sl-394\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\insrsid8718645 profitable. This will mean that bananas do not face significant competitive }{\fs24\expnd0\expndtw-4\insrsid8718645 
constraints from other products, that is there are no other products that substitute enough for bananas for the hypothetical monopolist to lose much demand when it }{\fs24\expnd0\expndtw-1\insrsid8718645 
raises the prices of bananas. Accordingly, bananas should be considered as a }{\fs24\insrsid8718645 separate market, and the test has already given its response.}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb245\sl-398\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs24\expnd0\expndtw-3\insrsid8718645 Suppose now instead that the hypothetical monopolist would not find it profitable }{\fs24\expnd0\expndtw-1\insrsid8718645 
to increase prices by that amount, for instance because after the price rise a }{\fs24\expnd0\expndtw-4\insrsid8718645 significant part of demand is redirected from bananas to kiwi fruits and to a lesser }{\fs24\expnd0\expndtw-1\insrsid8718645 
extent to pineapplies and other fruits. Then this will imply that bananas should }{\fs24\expnd0\expndtw-3\insrsid8718645 not be considered as a separate market on their own, as their exist other products }{\fs24\expnd0\expndtw-4\insrsid8718645 
that exercise a competitive constraint on sellers of bananas. The test should then }{\fs24\insrsid8718645 continue, to consider a wider market, for instance bananas and kiwi fruits }{\fs24\expnd0\expndtw-2\insrsid8718645 
together. Would a hypothetical monopolist that is the only seller of banana and }{\fs24\expnd0\expndtw-4\insrsid8718645 kiwi fruits find it profitable to increase the price of these fruits abov
e their current level by 5-10%. Again, if the price rise is profitable the relevant market for our }{\fs24\expnd0\expndtw-3\insrsid8718645 investigation will be found. Otherwise, the test should continue to include those }{
\fs24\expnd0\expndtw-1\insrsid8718645 products/fruits that exercise a constraint on bananas and kiwi fruits, and so on }{\fs24\insrsid8718645 until a separate market has been found.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 In short, a market does not define itself. It is determined by the demand side }{\fs28\expnd0\expndtw-3\insrsid8718645 
substitution and the supply side substitution of customers and producers respectively. In so assessing the scope of the referral market, there is a need }{\fs28\insrsid8718645 
to enquire as to the extent to which customers may switch to alternate products in the event of a price increase and the ability of competing }{\fs28\expnd0\expndtw-4\insrsid8718645 
producers to other alternate product offerings employed by the Tribunal in }{\fs28\expnd0\expndtw-3\insrsid8718645 arriving at its finding. Hence there is a need to enquire into the evidence }{\fs28\insrsid8718645 
employed by the Tribunal in arriving at its finding.}{\insrsid8718645 
\par }\pard \qj \fi72\li0\ri43\sb211\sl-480\slmult0\nowidctlpar\faauto\rin43\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [32] }{\fs28\ul\insrsid8718645 Mr Berger}{\fs28\insrsid8718645 
 contended that the appellants seek to widen their market definition.  It was his contention that appellants should be bound to their}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 17}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd-1\expndtw-5\insrsid8718645 original statements of the merger information filed of record, where they had }{\fs28\expnd0\expndtw-2\insrsid8718645 
described the relevant market as \lquote the administration of capitated managed }{\fs28\expnd0\expndtw-4\insrsid8718645 care options\rquote . He further submitted that the evidence that was placed before }{\fs28\insrsid8718645 
the Tribunal established, on a balance of probabilities, that capitated }{\fs28\expnd0\expndtw-1\insrsid8718645 managed care is the only effective arrangement of providing affordable }{\fs28\insrsid8718645 medical insurance to the poorest of the employed.
}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [33] It does appear that the appellants may have created the confusion when }{\fs28\insrsid8718645 
they stated in their original statements of the proposed merger that the }{\fs28\expnd-1\expndtw-5\insrsid8718645 relevant market was described as \'93administration of capitated managed care }{\fs28\expnd0\expndtw-4\insrsid8718645 options.\'94
 The Tribunal\rquote s reliance upon the initial filing does run the risk of }{\fs28\insrsid8718645 elevating the CC 4(2) form to the status of pleadings It also ignores subsequent exchanges between the parties. By the time the respondent }{
\fs28\expnd0\expndtw-1\insrsid8718645 submitted its recommendation on 30 June 2005, the information provided }{\fs28\insrsid8718645 by the merging parties extended far beyond the initial merger filing \endash  }{\fs28\expnd-1\expndtw-5\insrsid8718645 
particularly in relation to the definition of the product market. That this had }{\fs28\insrsid8718645 been imparted to respondent is borne out by the recommendation itself, }{\fs28\expnd0\expndtw-1\insrsid8718645 
where the respondent concluded that the relevant product market is \'93the }{\fs28\expnd-1\expndtw-6\insrsid8718645 market for the provision of managed care services with a national network of }{\fs28\insrsid8718645 service providers.\'94}{
\insrsid8718645 
\par }\pard \ql \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 [34] It must also be borne in mind that regard must be had to the totality of }{\fs28\expnd-1\expndtw-5\insrsid8718645 
the evidence as well as the applicable principles set out above in determining }{\fs28\expnd0\expndtw-3\insrsid8718645 the market. That evidence includes the testimony of witnesses called by the }{\fs28\insrsid8718645 
Tribunal and respondent, which   evidence reveals that capitation is but a model used by a party within a market.}{\insrsid8718645 
\par }\pard \ql \li72\ri0\sb317\nowidctlpar\faauto\rin0\lin72\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 Mr Dorfling, who testified on behalf of appellants said:}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 18}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\insrsid8718645 \'93I think capitation is normally sort of seen as managed care and I }{\fs28\expnd0\expndtw-1\insrsid8718645 think that\rquote 
s an incorrect perception. As I said, capitation is only one }{\fs28\insrsid8718645 of the tools. It\rquote s sort of the impression that\rquote s been given is that }{\fs28\expnd0\expndtw-2\insrsid8718645 capitation equals managed ca
re due to the American experience and }{\fs28\expnd-1\expndtw-5\insrsid8718645 the Kiaza, the Kiaza, which is one of the big managed care models in }{\fs28\insrsid8718645 America, which primarily used capitation.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [35]The following exchange between Dr Stillman and Mr Berger was also }{\fs28\expnd0\expndtw-1\insrsid8718645 
relevant to this determination, particularly in the light of the importance }{\fs28\expnd0\expndtw-3\insrsid8718645 placed by the Tribunal and Mr Berger upon Dr Stillman\rquote 
s memorandum of 20 June 2000 in arriving at its conclusion about the referral market:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb230\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 \'93}{\fs28\ul\expnd0\expndtw-2\insrsid8718645 ADV BERGE R}{\fs28\expnd0\expndtw-2\insrsid8718645 
: According to Dr Nauta and I believe Dr Walters, }{\fs28\expnd0\expndtw-1\insrsid8718645 the aim of such an environment is to move towards capitating the }{\fs28\expnd0\expndtw-4\insrsid8718645 service provider as well, but that\rquote 
s not necessarily the position. In }{\fs28\insrsid8718645 Carecross for example some of the doctors are paid on a capitated basis, other doctors are not paid on a capitated basis. Do you understand that?}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\ul\expnd0\expndtw-1\insrsid8718645 DR STILLMAN:}{\fs28\expnd0\expndtw-1\insrsid8718645  My understanding is that when it comes to the }{
\fs28\expnd0\expndtw-3\insrsid8718645 providers, that there are various kinds of models that are used and in }{\fs28\expnd0\expndtw-4\insrsid8718645 some cases the provider has to bears and in other cases the provider is }{\fs28\insrsid8718645 
on a fee-for-service basis.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [36] In its determination, the Tribunal also relied upon the evidence of Mr }{\fs28\expnd-1\expndtw-5\insrsid8718645 
Strauss of Discovery Health who testified on behalf of respondent but with }{\fs28\insrsid8718645 regard to this key question of the market, nowhere did Mr Strauss gainsay}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 19}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb341\sl-461\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 the evidence of Dorfling and Stillman that capitation was but one of a variety of managed care techniques.}{\insrsid8718645 
\par }\pard \qj \li0\ri14\sb211\sl-480\slmult0\nowidctlpar\faauto\rin14\lin0\itap0 \cbpat8 {\fs28\expnd-1\expndtw-5\insrsid8718645 A further exchange between Mr Berger and Dr Stillman reveals the approval }{\fs28\insrsid8718645 
adopted by the latter to capitation:}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 \'93Yes, but Dr Stillman, you will forgive me. I am concentrating on the capitated managed care market.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb317\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 DR STILLMAN}{\b\fs28\expnd0\expndtw-4\insrsid8718645 : }{\fs28\expnd0\expndtw-4\insrsid8718645 But I don\rquote t understand what you mean by that.
}{\insrsid8718645 
\par }\pard \qj \li0\ri24\sb264\sl-466\slmult0\nowidctlpar\faauto\rin24\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 ADV. BERGER: Well I thought we had gone through that, but let me try again The capitated managed 
care market is the market where a managed }{\fs28\expnd0\expndtw-3\insrsid8718645 care organisation takes the risk, assumes the risk from the scheme in return }{\fs28\insrsid8718645 for a capitation fee.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb322\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 DR STILLMAN}{\b\fs28\expnd0\expndtw-4\insrsid8718645 : }{\fs28\expnd0\expndtw-4\insrsid8718645 That is a business model. That doesn\rquote 
t make it a market.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb264\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 The distinction between a market and a business market was never }{\fs28\expnd0\expndtw-3\insrsid8718645 
adequately gainsayed by other witnesses. The Tribunal\rquote s use of evidence in }{\fs28\insrsid8718645 support of its conclusions at least in part, somewhat problematic. For }{\fs28\expnd0\expndtw-4\insrsid8718645 
example, the Tribunal employed the evidence of Dr R Nauta, the founder of }{\fs28\expnd0\expndtw-2\insrsid8718645 Carecross, to justify its conclusion that }{\i\fs28\expnd0\expndtw-2\insrsid8718645 \'93much of the evidence before us }{
\i\fs28\insrsid8718645 regards capitation as an essential element of a managed care product }{\i\fs28\expnd0\expndtw-1\insrsid8718645 directed at providing health insurance for low-income consumers. This is }{\i\fs28\expnd0\expndtw-2\insrsid8718645 
not to deny Dr Walters\rquote  contention that full capitation lies at th e end of a }{\i\fs28\expnd-1\expndtw-7\insrsid8718645 long journey that may begin with varying mechanisms for managing a fee-}{\i\fs28\expnd0\expndtw-3\insrsid8718645 
for-service arrangement and that ultimately ends with full risk transfer, (in }{\i\fs28\expnd0\expndtw-2\insrsid8718645 the form of capitation) is required if healthcare provision is to be extended}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 20}{\insrsid8718645 
\par }\pard \qj \li0\ri14\sb336\sl-466\slmult0\nowidctlpar\faauto\rin14\lin0\itap0 \cbpat8 {\i\fs28\expnd0\expndtw-4\insrsid8718645 on a significant scale to low-income earners. Dr Nauta contends that the }{\i\fs28\expnd0\expndtw-1\insrsid8718645 
transfer of risk \'93\'85is really critical too the success in this market. You\rquote ve }{\i\fs28\expnd0\expndtw-4\insrsid8718645 got to ultimately transfer risk from you as entity in the middle, that buys this from
 various options and various schemes, to the doctor\'94 (para 113).}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb322\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 In context, this passage of Dr Nauta\rquote s evidence reads:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb264\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 \'93
Are you aware of any other managed care companies that have attempted or companies that have attempted to enter this capitated }{\fs28\insrsid8718645 managed care market?}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 DR NAUTA}{\b\fs28\expnd0\expndtw-4\insrsid8718645 : }{\fs28\expnd0\expndtw-4\insrsid8718645 Yeah, no, I think it\rquote 
s true what I heard earlier. There }{\fs28\expnd0\expndtw-3\insrsid8718645 are\'85many people enter this. They go as fast as they come. It\rquote s not }{\fs28\insrsid8718645 difficult to enter this market. You basically need to have a }{
\fs28\expnd-1\expndtw-5\insrsid8718645 spreadsheet and a few bop in your pocket, because to say I\rquote m going to }{\fs28\expnd0\expndtw-4\insrsid8718645 do this and then the examples of that and the skeletons, you know, in }{
\fs28\expnd-1\expndtw-5\insrsid8718645 the past are there. We only think that there are about 3 of us that got }{\fs28\expnd0\expndtw-4\insrsid8718645 enough lives and members to retain the attention of the doctor and of }{\fs28\insrsid8718645 
the member, so that members didn\rquote t churn, what we say in the }{\fs28\expnd0\expndtw-3\insrsid8718645 medical industry \endash  in other words, come and go and come and go \endash  }{\fs28\expnd0\expndtw-4\insrsid8718645 
which is normally a broker induced thing if there\rquote s unhappiness in a }{\fs28\insrsid8718645 particular scheme or platform.\'94}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb230\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 This is hardly a definitive statement in support of the Tribunals caution }{\fs28\insrsid8718645 regarding capitation as a market.}{
\insrsid8718645 
\par }\pard \qj \li0\ri0\sb216\sl-470\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [37] In summary, the evidence shows that a capitation agreement which is a }{\fs28\insrsid8718645 
subset within the range of managed healthcare is an arrangement entered }{\fs28\expnd0\expndtw-2\insrsid8718645 into between a medical scheme and a person in terms of which the medical}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 21}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 sche me pays to such a person a pre-negotiated fixed fee in return for the }{\fs28\expnd0\expndtw-3\insrsid8718645 
delivery or arrangement for the delivery of specified benefits to some or all }{\fs28\insrsid8718645 of the members of the medical scheme. Apart from capitation, there are many options by which the provision of managed healthcare can be }{
\fs28\expnd0\expndtw-1\insrsid8718645 achieved. These include risk-adjusted global fee for service; risk-adjusted }{\fs28\expnd0\expndtw-4\insrsid8718645 fee for service; performance-based re-imbursement of global fee for service; }{\fs28\insrsid8718645 
peer review management, preferred provider accreditation and benefit design.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb941\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [38] The Tribunal\rquote s own approach is also not free of contradiction. In its }{\fs28\expnd0\expndtw-4\insrsid8718645 
market definition, the Tribunal concluded that the relevant market included }{\fs28\expnd0\expndtw-2\insrsid8718645 firms that provide capitated primary managed care options for both low-}{\fs28\expnd0\expndtw-1\insrsid8718645 
income and high/middle-income options. In short, the defined market was }{\fs28\expnd0\expndtw-3\insrsid8718645 not qualified by income sectors. When analysing barriers to entry however, }{\fs28\expnd-1\expndtw-5\insrsid8718645 
the Tribunal changed the scope of its analysis and deferred the market as the }{\fs28\expnd0\expndtw-4\insrsid8718645 provision of managed care options to the low income sector only. In other }{\fs28\expnd-1\expndtw-5\insrsid8718645 
words, the Tribunal now imposed a further restriction and excluded the high-}{\fs28\expnd0\expndtw-2\insrsid8718645 income and middle-income sectors. Thus it states at para 162:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 \'93We note that the schemes which Walters claims are about to desert }{\fs28\insrsid8718645 
Prime Cure and Carecross in favour of Solutio, appear to fit this }{\fs28\expnd0\expndtw-1\insrsid8718645 profile. If one accepts that much of the growth in the low -income market is going to be in large, national open schemes, this does not, }{
\fs28\expnd0\expndtw-4\insrsid8718645 on its own, suggest a significant future role in the relevant market for }{\fs28\insrsid8718645 Solutio.\'94}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 22}{\insrsid8718645 
\par }\pard \qj \li0\ri29\sb336\sl-466\slmult0\nowidctlpar\faauto\rin29\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 In my view it is inconsistent for the Tribunal to rely on a market definition }{\fs28\expnd-1\expndtw-5\insrsid8718645 including 
\'93capitated primary managed healthcare\'94 generally (which market }{\fs28\insrsid8718645 includes first appellant) and then later in the same determination to insist }{\fs28\expnd-1\expndtw-5\insrsid8718645 
that the relevant barriers ar e those in respect of entry into the lower income }{\fs28\expnd0\expndtw-4\insrsid8718645 sector (a sector in which first appellant does not operate),}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [39] For these reasons, the Tribunal erred in its definition of the product market. To return to the Tribunal\rquote 
s approach regarding market definition, }{\fs28\expnd0\expndtw-4\insrsid8718645 there is an unfortunate absence of a rigorous exercise to determine the scope }{\fs28\insrsid8718645 and nature of the market. The Tribunal did not perform any of the }{
\fs28\expnd-1\expndtw-5\insrsid8718645 traditional exercises used for determining the dimensions of product market. }{\fs28\expnd0\expndtw-2\insrsid8718645 There is no analysis in its determination which sector to compare prices of }{
\fs28\expnd0\expndtw-3\insrsid8718645 competing products or the functionality of those products from a consumer }{\fs28\expnd0\expndtw-4\insrsid8718645 perspective. No customer substitution test was performed: that is an analysis }{\fs28\insrsid8718645 
of price substitutability or functional substitutability. On the available }{\fs28\expnd-1\expndtw-5\insrsid8718645 evidence, the relevant product market appears to be the provision of primary }{\fs28\expnd0\expndtw-4\insrsid8718645 
managed healthcare products for low cost medical scheme options.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb331\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs28\expnd-1\expndtw-5\insrsid8718645 Competitors.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb250\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [40] The next question that has to be determined is the identification of the }{\fs28\expnd0\expndtw-1\insrsid8718645 
competitors. The evidence reveals that there are various entities which competed with second appellant, including third party managed care organisations, (\'93the MCO\rquote S\'94) , the medical scheme administrators as well }{
\fs28\expnd0\expndtw-2\insrsid8718645 as the independent practitioners\rquote  associations commonly known as IPA\rquote s.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb226\sl-480\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [41] In regard to the managed care organisations, the evidence revealed that }{\fs28\expnd0\expndtw-2\insrsid8718645 
Carecross as well as Faranani compete with the second appellant. Dr Nauta}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 23}{\insrsid8718645 
\par }\pard \qj \li0\ri19\sb341\sl-461\slmult0\nowidctlpar\faauto\rin19\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 testified that Faranani was established by IPA members and has fewer lives }{\fs28\expnd0\expndtw-1\insrsid8718645 
than Carecross and the second appellant, but continues to compete in the }{\fs28\insrsid8718645 same market. He then went on to testify as follows:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\insrsid8718645 \'93}{\fs28\ul\insrsid8718645 Mr Unterhalter}{\fs28\insrsid8718645 : But let\rquote s just examine some of the facts. I was }{
\fs28\expnd-1\expndtw-5\insrsid8718645 asking you a question as to who you would think your competitors are }{\fs28\expnd0\expndtw-1\insrsid8718645 and I think we had got to, well, you don\rquote t think Medicross, you do }{\fs28\insrsid8718645 
think Prime Cure. Who else? Is that it?}{\insrsid8718645 
\par }{\fs28\ul\insrsid8718645 DR NAUTA}{\fs28\insrsid8718645 : No, look I think there are probably let\rquote s say a new }{\fs28\expnd-1\expndtw-5\insrsid8718645 world that you may have in your mind somewhere there, that I don\rquote t }{
\fs28\insrsid8718645 really see as a competitor, but they are the managed care entities }{\fs28\expnd-1\expndtw-5\insrsid8718645 within administrators. The ones that jump to mind immediately would }{\fs28\expnd-1\expndtw-6\insrsid8718645 
be Qualsa, who have in fact poached 920 lives from us and then sent a }{\fs28\expnd0\expndtw-3\insrsid8718645 letter to all our doctors and that was a little (inaudible) group. So we were a bit vulnerable there. There is the Solutio Group, who look at }{
\fs28\expnd0\expndtw-4\insrsid8718645 hospital risks and they\rquote re part of the medscheme stable and then you }{\fs28\insrsid8718645 have a lot of little ones.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb926\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [42] The medical scheme administrators also compete in the same market, }{\fs28\expnd0\expndtw-1\insrsid8718645 
some of which provide the service \'93in house\'94. Dr Strauss testified that }{\fs28\expnd0\expndtw-4\insrsid8718645 Discovery had previously engaged the second appellant and Carecross to }{\fs28\insrsid8718645 
provide all primary health care benefits on their behalf. Subsequently }{\fs28\expnd0\expndtw-2\insrsid8718645 Discovery has terminated that contract and intends to render the service on }{\fs28\insrsid8718645 its own from 1 January 2006. Significa
ntly, it has 90 000 of the 342 000 }{\fs28\expnd0\expndtw-4\insrsid8718645 lives which comprise the number of lives covered by capitated options.}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 24}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [43] Solutio is the managed care division of Medscheme. Dr Walters }{\fs28\expnd0\expndtw-4\insrsid8718645 
testified that Solutio has since 2002 contracted 4000 practices to its network. }{\fs28\expnd0\expndtw-1\insrsid8718645 Some of these practices have two to three doctors. Furthermore, twelve }{\fs28\insrsid8718645 
schemes have contracted with Solutio to gain access to its network of }{\fs28\expnd0\expndtw-4\insrsid8718645 medical practitioners. Dr Walters testified that Solutio regarded the second appellant, Carecross
, Faranani, Discovery and Qualsa as its competitors and }{\fs28\expnd-1\expndtw-5\insrsid8718645 that it has on certain instances been appointed to provide services which had }{\fs28\insrsid8718645 been previously provided by the second appellant.}{
\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 [44] Qualsa is a managed healthcare organisation within the Metropolitan }{\fs28\expnd0\expndtw-3\insrsid8718645 
Health Group. It provides primary care services for Wooltru, previously }{\fs28\expnd0\expndtw-2\insrsid8718645 provided by Carecross and the second appellant. It has 40 000 lives. Mr }{\fs28\expnd0\expndtw-1\insrsid8718645 
Dorfling testified that Qualsa also provides managed care services to the }{\fs28\expnd0\expndtw-2\insrsid8718645 Pick \rquote n Pay Medical Scheme. Mx Health is a large administrator that has a }{\fs28\insrsid8718645 
managed care division, thus providing similar services provided by the second appellant. Enablemed has recently been awarded a contract in }{\fs28\expnd0\expndtw-1\insrsid8718645 respect of the Nissan Medical Scheme involving 6000 lives. This scheme }{
\fs28\insrsid8718645 was previously handled by the second appellant .}{\insrsid8718645 
\par }\pard \qj \fi72\li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [45] The Independent Practitioners Associations also have a national }{\fs28\expnd0\expndtw-1\insrsid8718645 
footprint. Mr Singh testified that the IPA\rquote s are all doctors and the location }{\fs28\expnd0\expndtw-3\insrsid8718645 of their practices is convenient for the member and his or her family. The }{\fs28\expnd0\expndtw-4\insrsid8718645 IPA\rquote 
s have organised themselves as businesses in order to provide managed }{\fs28\expnd0\expndtw-3\insrsid8718645 care services to medical schemes. In this regard Sizwe Medical Fund has }{\fs28\expnd0\expndtw-2\insrsid8718645 
concluded contractual arrangements with the IPA\rquote s only .}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [46] It is evident that there are a number of organisations with financial }{\fs28\insrsid8718645 
resources and administrative networks in the market, whilst some are}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 25}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb336\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 preparing to enter the market. In my view, the Tribunal did not attach }{\fs28\expnd-1\expndtw-5\insrsid8718645 
sufficient we ight to this evidence. It is highly unlikely that Discovery, an }{\fs28\expnd0\expndtw-4\insrsid8718645 experienced administrator, will encounter any major difficulties when it commences providing the service \'93in house\'94
 from January 2006. It has the }{\fs28\expnd0\expndtw-2\insrsid8718645 financial means and network, and furthermore has 90 000 lives with which }{\fs28\expnd0\expndtw-4\insrsid8718645 to commence with. Indeed respondent\rquote 
s own expert, Mr J Hodge, conceded that Discovery was \lquote a real competitor\rquote . Similarly, Solutio is a competitor of the second appellant. Dr Walters provided evidence that Solutio had entered }{\fs28\expnd0\expndtw-2\insrsid8718645 
the market to provide primary care services for managed care options and }{\fs28\expnd0\expndtw-4\insrsid8718645 had done so in competition with second appellant and Carecross.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb922\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 
[47] Th e Tribunal erred in rejecting this evidence without justification. It erred in its identification of the competitors of the second appellant. It is evident that the competitors of Prime Cure, the second appellant, consisted }{\fs28\insrsid8718645 
of various entities namely, Carecross, Solutio, Discovery, Qualsa, Enablemed, Faranani, Mx Health as well as the IPA\rquote s.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [48] Having defined the product market and identified the competitors, I }{\fs28\expnd0\expndtw-3\insrsid8718645 turn to
 deal albeit, briefly, with the remaining issues raised by the parties. These related to the findings by the Tribunal on price sensitivity; switching between medical schemes; competition in the market as well as barriers to }{\fs28\insrsid8718645 entry.}{
\insrsid8718645 
\par }\pard \ql \li0\ri0\sb336\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 (i) }{\fs28\ul\expnd0\expndtw-4\insrsid8718645 Price sensitivity}{\insrsid8718645 
\par }\pard \qj \li0\ri29\sb101\sl-466\slmult0\nowidctlpar\faauto\rin29\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [49] In regard to price sensitivity the evidence clearly reveals that the low }{\fs28\insrsid8718645 
income members are sensitive   to price increases and that members will}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 26}{\insrsid8718645 
\par }\pard \qj \li0\ri10\sb336\sl-466\slmult0\nowidctlpar\faauto\rin10\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 migrate if there was any mention of a price increase, however minute. This }{\fs28\expnd-1\expndtw-5\insrsid8718645 view was h
eld by various witnesses, including Mr Van der Heever called by }{\fs28\expnd0\expndtw-2\insrsid8718645 the Tribunal who replied to a question of sensitivity to price changes as }{\fs28\insrsid8718645 follows:}{\insrsid8718645 
\par }\pard \qj \li706\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin706\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 \lquote I think that yes, I think that looking at the sort of absolute levels, the }{\fs28\expnd-1\expndtw-5\insrsid8718645 
sort of price elasticity at the lower end, I would expect they would be }{\fs28\expnd0\expndtw-3\insrsid8718645 very price sensitive to changes as well to the absolute level of cost at }{\fs28\expnd0\expndtw-4\insrsid8718645 this point in time. Mr Hodge
\rquote s testimony in this regard is particularly }{\fs28\expnd-1\expndtw-5\insrsid8718645 telling. We also acknowledge this is a price sensitive market, as a low-}{\fs28\expnd0\expndtw-4\insrsid8718645 
income market, but what the parties are actually suggesting is that it\rquote s }{\fs28\expnd0\expndtw-1\insrsid8718645 perfectly price sensitive, which is a completely different game and }{\fs28\expnd-1\expndtw-7\insrsid8718645 
from our perspective, if we are going to take pr ice sensitivity on the }{\fs28\expnd0\expndtw-1\insrsid8718645 low-income market to its logical conclusion, then we wouldn\rquote t be }{\fs28\expnd0\expndtw-4\insrsid8718645 
hearing cases in the Competition Tribunal on low-income products.\rquote }{\insrsid8718645 
\par }\pard \qj \li0\ri14\sb235\sl-466\slmult0\nowidctlpar\faauto\rin14\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 
To elevate the indicated test to that of perfect price sensitivity is to construct a test in favour of respondent which in practice will hardly, if ever be met!}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb221\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [50] Mr van der Heever\rquote s concession was wisely made. Members or }{\fs28\expnd0\expndtw-2\insrsid8718645 
consumers with very little disposable income are likely to remain sensitive }{\fs28\expnd0\expndtw-4\insrsid8718645 to price increases. If the price is increased, they may not be able to afford }{\fs28\expnd0\expndtw-3\insrsid8718645 
membership of the scheme and this will cause them to move or switch to a medical scheme that will suit their needs and pockets. Any attempt by the }{\fs28\expnd0\expndtw-1\insrsid8718645 
appellants to increase the price if the proposed merger is granted may well be met by an exodus of members who are price sensitive. This prediction }{\fs28\insrsid8718645 finds
 clear support in the evidence of Dr Nauta who conceded under the cross examination that low income earners would \lquote simply move away\rquote  if}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\insrsid8718645 27}{\insrsid8718645 
\par }\pard \qj \li0\ri10\sb341\sl-461\slmult0\nowidctlpar\faauto\rin10\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-4\insrsid8718645 price was increased significantly. It follows therefore that the Tribunal erred }{\fs28\expnd0\expndtw-2\insrsid8718645 
when it found that the low income consumers become insensitive to price }{\fs28\insrsid8718645 once they have joined the scheme.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb322\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 (ii) }{\fs28\ul\expnd0\expndtw-3\insrsid8718645 Switching between medical schemes}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb278\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 [51] The Tribunal found that the members are unlikely to switch from one }{\fs28\expnd0\expndtw-4\insrsid8718645 
medical aid to another due to price increases. In my view there is no clear }{\fs28\insrsid8718645 impediment precluding the members from switching. They do not forfeit }{\fs28\expnd-1\expndtw-5\insrsid8718645 
any money if they move but may be required to wait for a period before the }{\fs28\insrsid8718645 benefits accrue to them. In any event this finding by the Tribunal is not clearly supported by any evidence.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb317\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\ul\expnd0\expndtw-4\insrsid8718645 (iii) Barriers to entry}{\insrsid8718645 
\par }\pard \qj \li0\ri24\sb101\sl-466\slmult0\nowidctlpar\faauto\rin24\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-1\insrsid8718645 
[52] The Tribunal concluded that the entry barriers are formidable. It is difficult to comprehend how that finding was made when regard is had to }{\fs28\insrsid8718645 the evidence. There are competitors in the market. The evidence of Dr }{
\fs28\expnd0\expndtw-4\insrsid8718645 Nauta on whom the Tribunal relied was that it was not difficult to enter the }{\fs28\insrsid8718645 market. Dr Nauta\rquote s evidence is revealing.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 As noted, when he was asked the question: \'93Are you aware of any other }{\fs28\insrsid8718645 managed c
are companies that have attempted or companies that have }{\fs28\expnd0\expndtw-2\insrsid8718645 attempted to enter this capitated managed care market?\'94, Dr Nauta replied }{\fs28\expnd0\expndtw-1\insrsid8718645 
that entry into the market is easy; the difficulty of being successful was }{\fs28\insrsid8718645 another matter.}{\insrsid8718645 
\par }\pard \qj \li0\ri10\sb211\sl-480\slmult0\nowidctlpar\faauto\rin10\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 But, Discovery has a good network and sound financial backing with 90 }{\fs28\expnd0\expndtw-3\insrsid8718645 
000 lives and would not face any barriers upon entry. Solutio has more than}{\insrsid8718645 
\par \sect }\sectd \linex0\colsx60\sectdefaultcl\sftnbj \pard\plain \qc \li5\ri0\nowidctlpar\faauto\rin0\lin5\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\fs24\expnd0\expndtw-2\insrsid8718645 28}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb341\sl-461\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 4000 practices in its network. Old Mutual has the financial and }{\fs28\expnd0\expndtw-3\insrsid8718645 
administrative resources necessary to enter the market. It has also acquired Sizwe Medical Scheme, which has an arrangement with IPA\rquote s.}{\insrsid8718645 
\par }\pard \qj \li0\ri5\sb941\sl-466\slmult0\nowidctlpar\faauto\rin5\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-3\insrsid8718645 In coming to its conclusion the Tribunal sought to circumvent Dr Nauta\rquote s }{\fs28\expnd0\expndtw-2\insrsid8718645 
evidence by emphasizing the tests of continued presence in the market as }{\fs28\expnd0\expndtw-4\insrsid8718645 opposed to focusing upon entry. But as I have noted, not even that predictive }{\fs28\expnd-1\expndtw-5\insrsid8718645 
conclusion has been justified nor is there a basis to conclude with confidence }{\fs28\expnd0\expndtw-4\insrsid8718645 that it can be sustained on the evidence. The Tribunal accordingly erred in }{\fs28\insrsid8718645 
finding that there were significant barriers to entry.}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb1022\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs28\expnd-1\expndtw-8\insrsid8718645 Conclusion.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb250\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\expnd0\expndtw-2\insrsid8718645 [53] It follows therefore that this was not a \'93three to two merger\'94 as found }{\fs28\expnd0\expndtw-3\insrsid8718645 
by the Tribunal. There are other competitors with sound financial and }{\fs28\expnd0\expndtw-4\insrsid8718645 administrative networks. Some of the competitors have managed to secure }{\fs28\expnd-1\expndtw-5\insrsid8718645 market share which had pr
eviously been held by the second appellant. The }{\fs28\expnd0\expndtw-1\insrsid8718645 evidence has clearly established that there is aggressive competition, that }{\fs28\expnd0\expndtw-3\insrsid8718645 
each player has to provide good if not excellent service, in order to keep its }{\fs28\insrsid8718645 contracts. On the evidence presented to the Tribunal there was an }{\fs28\expnd0\expndtw-4\insrsid8718645 
insufficient basis to conclude that the horizontal dimensions of the merger would result in a lessening of competition in the deferred market.}{\insrsid8718645 
\par }\pard \qj \li0\ri0\sb235\sl-466\slmult0\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\fs28\insrsid8718645 [54] It follows that the appeal was upheld and the order approving the merger was granted.}{\insrsid8718645 
\par \sect }\sectd \margrsxn1809\linex0\cols2\colno1\colw4598\colsr1910\colno2\colw1838\sectdefaultcl\sftnbj \pard\plain \ql \li4066\ri0\nowidctlpar\faauto\rin0\lin4066\itap0 \cbpat8 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {
\fs24\insrsid8718645 29}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb2846\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\b\fs24\expnd-1\expndtw-8\insrsid8718645 DAVIS J P AND SELIKOWITZ JA AGREED}{\insrsid8718645 
\par }\pard \ql \li0\ri0\sb1800\nowidctlpar\faauto\rin0\lin0\itap0 \cbpat8 {\insrsid8718645 \column }{\b\fs24\expnd-2\expndtw-10\insrsid8718645 MHLANTLA AJA}{\insrsid8718645 
\par }}